ATNM
Price
$1.78
Change
-$0.12 (-6.32%)
Updated
Oct 3 closing price
21 days until earnings call
VYGR
Price
$5.99
Change
+$0.17 (+2.92%)
Updated
Oct 3 closing price
32 days until earnings call
Ad is loading...

ATNM vs VYGR

Header iconATNM vs VYGR Comparison
Open Charts ATNM vs VYGRBanner chart's image
Actinium Pharmaceuticals
Price$1.78
Change-$0.12 (-6.32%)
Volume$317.68K
CapitalizationN/A
Voyager Therapeutics
Price$5.99
Change+$0.17 (+2.92%)
Volume$567.46K
CapitalizationN/A
View a ticker or compare two or three
ATNM vs VYGR Comparison Chart
Loading...
ATNM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ATNM vs. VYGR commentary
Oct 04, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATNM is a StrongBuy and VYGR is a Sell.

COMPARISON
Comparison
Oct 04, 2024
Stock price -- (ATNM: $1.78 vs. VYGR: $5.99)
Brand notoriety: ATNM and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATNM: 31% vs. VYGR: 129%
Market capitalization -- ATNM: $56.08M vs. VYGR: $319.02M
ATNM [@Biotechnology] is valued at $56.08M. VYGR’s [@Biotechnology] market capitalization is $319.02M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATNM’s FA Score shows that 0 FA rating(s) are green whileVYGR’s FA Score has 1 green FA rating(s).

  • ATNM’s FA Score: 0 green, 5 red.
  • VYGR’s FA Score: 1 green, 4 red.
According to our system of comparison, VYGR is a better buy in the long-term than ATNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATNM’s TA Score shows that 3 TA indicator(s) are bullish while VYGR’s TA Score has 4 bullish TA indicator(s).

  • ATNM’s TA Score: 3 bullish, 3 bearish.
  • VYGR’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, VYGR is a better buy in the short-term than ATNM.

Price Growth

ATNM (@Biotechnology) experienced а -0.56% price change this week, while VYGR (@Biotechnology) price change was +1.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.64%. For the same industry, the average monthly price growth was +0.29%, and the average quarterly price growth was -7.26%.

Reported Earning Dates

ATNM is expected to report earnings on Oct 25, 2024.

VYGR is expected to report earnings on Nov 05, 2024.

Industries' Descriptions

@Biotechnology (+0.64% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VYGR($319M) has a higher market cap than ATNM($56.1M). VYGR YTD gains are higher at: -29.028 vs. ATNM (-64.961). VYGR has higher annual earnings (EBITDA): -1.78M vs. ATNM (-45.91M). VYGR has more cash in the bank: 371M vs. ATNM (86M). ATNM has less debt than VYGR: ATNM (1.85M) vs VYGR (46.9M). VYGR has higher revenues than ATNM: VYGR (144M) vs ATNM (81K).
ATNMVYGRATNM / VYGR
Capitalization56.1M319M18%
EBITDA-45.91M-1.78M2,573%
Gain YTD-64.961-29.028224%
P/E RatioN/A21.67-
Revenue81K144M0%
Total Cash86M371M23%
Total Debt1.85M46.9M4%
FUNDAMENTALS RATINGS
ATNM vs VYGR: Fundamental Ratings
ATNM
VYGR
OUTLOOK RATING
1..100
7565
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
59
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9880
PRICE GROWTH RATING
1..100
9585
P/E GROWTH RATING
1..100
1002
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VYGR's Valuation (59) in the Biotechnology industry is in the same range as ATNM (78). This means that VYGR’s stock grew similarly to ATNM’s over the last 12 months.

VYGR's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ATNM (100). This means that VYGR’s stock grew similarly to ATNM’s over the last 12 months.

VYGR's SMR Rating (80) in the Biotechnology industry is in the same range as ATNM (98). This means that VYGR’s stock grew similarly to ATNM’s over the last 12 months.

VYGR's Price Growth Rating (85) in the Biotechnology industry is in the same range as ATNM (95). This means that VYGR’s stock grew similarly to ATNM’s over the last 12 months.

VYGR's P/E Growth Rating (2) in the Biotechnology industry is significantly better than the same rating for ATNM (100). This means that VYGR’s stock grew significantly faster than ATNM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATNMVYGR
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
75%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 23 days ago
76%
Declines
ODDS (%)
Bearish Trend 8 days ago
86%
Bearish Trend 9 days ago
84%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
View a ticker or compare two or three
Ad is loading...
ATNM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TRSCX30.78-0.10
-0.32%
Nuveen Large Cap Responsible Eq Retire
CSVRX42.16-0.25
-0.59%
Columbia Small Cap Value I R
RRGAX7.59-0.05
-0.65%
DWS RREEF Global Real Estate Secc A
LYRZX12.37-0.10
-0.80%
Lyrical International Value Equity C
QTERX11.60-0.11
-0.94%
AQR Emerging Multi-Style II R6